1. Erbs, P., Regulier, E., Kintz, J., Leroy, P., Poitevin, Y., Exinger, F., Jund, R., and Mehtali, M., In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene, Cancer Res., 2000, vol. 60, pp. 3813–3822.
2. Graepler, F, Lemken, M.L., Wybranietz, W.A., Schmidt, U., Smirnow, I., Gross, C.D., Spiegel, M., Schenk, A., Graf, H., Lauer, U.A., Vonthein, R., Gregor, M., Armeanu, S., Bitzer, M., and Lauer, U.M., Bifunctional chimeric SuperCD suicide gene—YCD: YUPRT fusion is highly effective in a rat hepatoma model, World J. Gastroenterol., 2005, vol. 11, pp. 6910–6919.
3. Farokhimanesh, S., Rahbarizadeh, F., Rasaee, M.J., Kamali, A., and Mashkani, B., Hybrid promoters directed tBid gene expression to breast cancer cells by transcriptional targeting, Biotechnol. Prog., 2010, vol. 26, pp. 505–511.
4. Wirth, T., Zender, L., Schulte, B., Mundt, B., Plentz, R., Rudolph, K.L., Manns, M., Kubicka, S., and Kühnel, F., A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer, Cancer Res., 2003, vol. 63, pp. 3181–3188.
5. Kuzmin, D.V., Vinogradova, T.V., Kopantzev, E.P., and Sverdlov, E.D., Cre–LoxP mediated strong enhancement of pBIRC5 promoter driven suicide of cancer cells with CD/UPRT and fluorocytosine, Open Gene Ther. J., 2010, vol. 3, pp. 31–39.